1053 related articles for article (PubMed ID: 18275912)
1. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
3. Colloidal drug delivery system: amplify the ocular delivery.
Ali J; Fazil M; Qumbar M; Khan N; Ali A
Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
[TBL] [Abstract][Full Text] [Related]
5. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
6. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
7. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
8. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
9. Nanosuspensions: a promising drug delivery strategy.
Patravale VB; Date AA; Kulkarni RM
J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860
[TBL] [Abstract][Full Text] [Related]
10. Recent perspectives in ocular drug delivery.
Gaudana R; Jwala J; Boddu SH; Mitra AK
Pharm Res; 2009 May; 26(5):1197-216. PubMed ID: 18758924
[TBL] [Abstract][Full Text] [Related]
11. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Del Amo EM; Urtti A
Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
[TBL] [Abstract][Full Text] [Related]
12. Microspheres and Nanotechnology for Drug Delivery.
Jóhannesson G; Stefánsson E; Loftsson T
Dev Ophthalmol; 2016; 55():93-103. PubMed ID: 26501994
[TBL] [Abstract][Full Text] [Related]
13. Ocular drug delivery - a look towards nanobioadhesives.
du Toit LC; Pillay V; Choonara YE; Govender T; Carmichael T
Expert Opin Drug Deliv; 2011 Jan; 8(1):71-94. PubMed ID: 21174606
[TBL] [Abstract][Full Text] [Related]
14. Engineered nanoparticles as precise drug delivery systems.
Yih TC; Al-Fandi M
J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
[TBL] [Abstract][Full Text] [Related]
15. Contact lenses for drug delivery.
Ciolino JB; Dohlman CH; Kohane DS
Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
Attar M; Shen J; Ling KH; Tang-Liu D
Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
[TBL] [Abstract][Full Text] [Related]
20. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
